Developer of the ProLon® Fasting Mimicking Diet® (FMD®) and Fast Bar®, L-Nutra has established itself as a leading nutrition-technology company. To date, more than 12,000 healthcare professionals have registered to recommend and learn about ProLon, and more than 220,000 people have fasted with ProLon, in over 13 countries. The Fasting Mimicking Diet has been researched at leading academic medical centers, with numerous publications in Nature, Cell Metabolism, Science Translational Medicine and many other highly respected, peer-reviewed journals. Since its launch, L-Nutra has experienced rapid growth that continues to accelerate. The company has received extensive press coverage, and founder Dr. Valter Longo was selected among Time Magazine’s™ 50 most influential people in health care in 2018. With exceptionally talented scientific and business teams, L-Nutra is well positioned to drive true innovation in healthcare, and transform the global health and wellness market.